Ajay Wasan
Pain Medicine · Pittsburgh, PANPI 1962596163
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $62,143 of the $65,965 with a category attached, or 94.2%. 7 manufacturers reported payments, led by Vertex at 57.9% of the total. 2025 is the largest year on record at $26,628, more than ten times the $16 reported in 2019. Among pain medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $1434.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$38K
- Jazz Pharmaceuticals Inc.$13K
- GW Research Limited$8K
- Merck$7K
- Boston Scientific$263
- GRT US Holding, Inc.$76
- plus $42 from 1 others
What the payments were for
- Consulting fees$62,14394%
- Travel & lodging$3,0015%
- Food & beverage$8221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 25 | $38,180 |
| Jazz Pharmaceuticals Inc. | 1 | $12,572 |
| GW Research Limited | 3 | $7,633 |
| Merck | 10 | $7,200 |
| Boston Scientific | 3 | $263 |
| GRT US Holding, Inc. | 2 | $76 |
| Abbott | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$12,572
- WaveWriter Alpha Prime 16$134
- INFINION$112
How this compares
$65,965 in reported general payments places this provider in the 95th percentile of 294 pain medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 27 | $14,513 |
| Buprenorphine | 23 | $7,168 |
| HorizantGabapentin Enacarbil | 12 | $5,325 |
| Gabapentin | 260 | $2,968 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $2,829 |
| Duloxetine Hcl | 139 | $2,763 |
| Pregabalin | 105 | $1,486 |
| Methadone Hcl | 47 | $1,457 |
| Baclofen | 153 | $1,423 |
| Diclofenac Sodium | 38 | $1,233 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $812 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $659 |
| Oxycodone Hcl | 63 | $640 |
| Methocarbamol | 76 | $629 |
| Tizanidine Hcl | 93 | $550 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Pittsburgh
- Abraham KabaziePittsburgh$18K
- Michael HurPittsburgh$12K
- Feno MonacoPittsburgh$12K
- Danielle ZhengPittsburgh$10K
- Richard GaoPittsburgh$7K
- Peter PryzbylkowskiPhiladelphia$506K
- Yeshvant NavalgundGreensburg$388K
- Jack SmithWilliamsport$324K
- Sanjay GuptaBala Cynwyd$241K
- Vwaire OrhurhuWilliamsport$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.